MedTrace Logo

Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

NCT07186088 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-09-22

No results posted yet for this study

Summary

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

Conditions

  • Myopia

Interventions

DEVICE

Eyerising RS-200-2A

Eyerising RS-200-2A,1 time,2 times, 3 times a day

DEVICE

Airdoc Sky-n1201

Eyerising RS-200-2A,2 times a day

Sponsors & Collaborators

  • Tianjin Medical University Eye Hospital

    collaborator OTHER

  • Ruihua Wei

    lead OTHER

Principal Investigators

  • Ruihua Wei · Tianjin Medical University Eye Hospital, Tianjin, Tianjin 120120 Recruiting

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-20
Primary Completion
2026-03-20
Completion
2026-06-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07186088 on ClinicalTrials.gov